InvestSMART

Tissue Repair Ltd (ASX: TRP) - Announcements

- Current share price for TRP : $0.080

ASX company news and announcements for Tissue Repair Ltd (TRP) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Tissue Repair Ltd (TRP) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Tissue Repair Ltd (TRP), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Tissue Repair Ltd (TRP)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$5 Company Presentation 8 Nov 2022 9:57AM $0.290 $0.080 fallen by 72.41%
$5 Bell Potter Healthcare Conference Invitation 7 Nov 2022 7:05PM $0.290 $0.080 fallen by 72.41%
$5 Quarterly Activities/Appendix 4C Cash Flow Report 28 Oct 2022 9:11AM $0.270 $0.080 fallen by 70.37%
$5 Notice of Annual General Meeting/Proxy Form 21 Oct 2022 11:10AM $0.295 $0.080 fallen by 72.88%
$5 TR Pro accepted for peer reviewed journal publication 12 Oct 2022 6:56PM $0.275 $0.080 fallen by 70.91%
$5 Change of Company Secretary 28 Sep 2022 11:48AM $0.300 $0.080 fallen by 73.33%
$5 FDA Response Clarifies Path to Phase 3 Trials 28 Sep 2022 11:33AM $0.300 $0.080 fallen by 73.33%
$5 Second US Patent granted for Glucoprime 5 Sep 2022 10:00AM $0.310 $0.080 fallen by 74.19%
$5 Appendix 4G and Corporate Governance Statement 31 Aug 2022 3:48PM $0.340 $0.080 fallen by 76.47%
$5 Appendix 4E and Annual Report 30 June 2022 31 Aug 2022 3:40PM $0.340 $0.080 fallen by 76.47%
$5 Quarterly Activities/Appendix 4C Cash Flow Report 29 Jul 2022 8:15AM $0.310 $0.080 fallen by 74.19%
$5 Lodgement of Type C Meeting Request with US FDA 1 Jul 2022 9:50AM $0.250 $0.080 fallen by 68%
$5 Notice under ASX Listing Rule 3.10A 11 May 2022 5:03PM $0.285 $0.080 fallen by 71.93%
$5 Application for quotation of securities - TRP 3 May 2022 11:51AM $0.325 $0.080 fallen by 75.38%
$5 Quarterly Activities/Appendix 4C Cash Flow Report 29 Apr 2022 4:18PM $0.325 $0.080 fallen by 75.38%
$5 Notice under ASX Listing Rule 3.10A 22 Apr 2022 8:54AM $0.350 $0.080 fallen by 77.14%
$5 Change of Director's Interest Notice 29 Mar 2022 3:57PM $0.370 $0.080 fallen by 78.38%
$5 Tissue Repair Announces USA Patent Approval 4 Mar 2022 10:19AM $0.435 $0.080 fallen by 81.61%
$5 Appendix 4D and Half Year Report to 31 December 2021 25 Feb 2022 9:23AM $0.395 $0.080 fallen by 79.75%
$5 Quarterly Activities/Appendix 4C Cash Flow Report 31 Jan 2022 11:58AM $0.455 $0.080 fallen by 82.42%
$5 Correction to Appendix 3Y 8 Dec 2021 6:45PM $0.530 $0.080 fallen by 84.91%
$5 Tissue Repair Progresses TR-987 towards Phase III 23 Nov 2021 9:43AM $0.615 $0.080 fallen by 86.99%
$5 Change of Director's Interest Notice - Tony Charara 23 Nov 2021 9:38AM $0.615 $0.080 fallen by 86.99%
$5 Change of Director's Interest Notice - Jack Lowenstein 23 Nov 2021 9:36AM $0.615 $0.080 fallen by 86.99%
$5 Change of Director's Interest Notice - Max Johnston 23 Nov 2021 9:35AM $0.615 $0.080 fallen by 86.99%

101 - 125 of 192 results

Page 5 of 8

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.